These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37893115)

  • 1. Methoxyhispolon Methyl Ether, a Hispolon Analog, Thwarts the SRC/STAT3/BCL-2 Axis to Provoke Human Triple-Negative Breast Cancer Cell Apoptosis In Vitro.
    Liao CP; Hsieh YC; Lu CH; Dai WC; Yang WT; Cheng KT; Ramani MV; Subbaraju GV; Chang CC
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the SRC/STAT3/BCL-2 Signaling Axis Sustains the Cytotoxicity in Human Colorectal Cancer Cell Lines Induced by Dehydroxyhispolon Methyl Ether.
    Hsieh YC; Dai YC; Cheng KT; Yang WT; Ramani MV; Subbaraju GV; Chen YJ; Chang CC
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines.
    Kuo MY; Yang WT; Ho YJ; Chang GM; Chang HH; Hsu CY; Chang CC; Chen YH
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis.
    Fan HC; Hsieh YC; Li LH; Chang CC; Janoušková K; Ramani MV; Subbaraju GV; Cheng KT; Chang CC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hispolon induces apoptosis against prostate DU145 cancer cells via modulation of mitochondrial and STAT3 pathways.
    Masood M; Rasul A; Sarfraz I; Jabeen F; Liu S; Liu X; Wei W; Li J; Li X
    Pak J Pharm Sci; 2019 Sep; 32(5(Supplementary)):2237-2243. PubMed ID: 31894049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.
    Liu CY; Chen KF; Chao TI; Chu PY; Huang CT; Huang TT; Yang HP; Wang WL; Lee CH; Lau KY; Tsai WC; Su JC; Wu CY; Chen MH; Shiau CW; Tseng LM
    J Mol Med (Berl); 2017 Sep; 95(9):965-975. PubMed ID: 28578456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2/STAT3/BCL-xL signaling axis.
    Kuo MY; Dai WC; Chang JL; Chang JS; Lee TM; Chang CC
    Environ Toxicol; 2024 Jun; 39(6):3356-3366. PubMed ID: 38444163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells.
    Cheng YP; Li S; Chuang WL; Li CH; Chen GJ; Chang CC; Or CR; Lin PY; Chang CC
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro.
    Hsu CY; Yang WT; Lin JH; Lu CH; Hu KC; Lan TH; Chang CC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis.
    Park SJ; Jung HJ
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway.
    Xie Q; Yang Z; Huang X; Zhang Z; Li J; Ju J; Zhang H; Ma J
    J Hematol Oncol; 2019 Jun; 12(1):60. PubMed ID: 31186039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells.
    Tzeng YT; Liu PF; Li JY; Liu LF; Kuo SY; Hsieh CW; Lee CH; Wu CH; Hsiao M; Chang HT; Shu CW
    Front Pharmacol; 2018; 9():1285. PubMed ID: 30473665
    [No Abstract]   [Full Text] [Related]  

  • 15. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
    Kotha A; Sekharam M; Cilenti L; Siddiquee K; Khaled A; Zervos AS; Carter B; Turkson J; Jove R
    Mol Cancer Ther; 2006 Mar; 5(3):621-9. PubMed ID: 16546976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer.
    Jin LL; Lu HJ; Shao JK; Wang Y; Lu SP; Huang BF; Hu GN; Jin HC; Wang CQ
    Mol Cell Biochem; 2023 Dec; ():. PubMed ID: 38145448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells
    Lou C; Chen Y; Zhang J; Yang B; Zhao H
    Front Pharmacol; 2019; 10():1071. PubMed ID: 31607920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bioinformatic Strategy for Investigating the Mechanism of Hispolon in the Treatment of Triple-Negative Breast Cancer Combined with In vitro Experiments.
    Li J; Bao J; Wu L; Sun T; Zhao J; Luo F; Tao F; Liu W
    Curr Cancer Drug Targets; 2024 Aug; ():. PubMed ID: 39108110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
    Dees S; Pontiggia L; Jasmin JF; Mercier I
    Cancer Biol Ther; 2020 Jun; 21(6):506-521. PubMed ID: 32164483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.
    Sapio L; Sorvillo L; Illiano M; Chiosi E; Spina A; Naviglio S
    Molecules; 2015 Sep; 20(9):15910-28. PubMed ID: 26340617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.